Dermatology

Pérez-Chada LM, Hopkins ZH, Balak DMW, Rashid S, Creadore A, Chu B, Villa C, Woodbury MJ, Armstrong AW, Strand V, Gottlieb AB, Merola JF, Barbieri[...]

By sjmartinez • January 25, 2024

Mohamed MF, Qian Y, D'Cunha R, Sligh T, Ferris LK, Eldred A, Levy GF, Hao S, Gannu S, Rizzo DG, Liu W, Jazayeri S, Sofen[...]

By sjmartinez • January 25, 2024

Armstrong AW, Jayade S, Rege S, Joshi N, Patel V, Kalirai S, Wolin D, Boyle K, Patel D, Seigel L. Evaluating Treatment Choice in Patients[...]

By sjmartinez • January 23, 2024

Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Vritzali E, Napoli A, Kisa RM, Buck A, Banerjee[...]

By sjmartinez • January 17, 2024

Gilliet M, Modlin RL. Immunobiology of IL-26. J Invest Dermatol. 2024 Jan 8:S0022-202X(23)03124-X. doi: 10.1016/j.jid.2023.10.038. Epub ahead of print. PMID: 38206272.

By sjmartinez • January 12, 2024

Kingston P, Blauvelt A, Strober B, Armstrong AW. Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis. J Psoriasis Psoriatic Arthritis. 2023 Oct;8(4):156-165.[...]

By sjmartinez • January 8, 2024

Song WB, Garshick MS, Barbieri JS, Shin DB, Báez S, Papadopoulos M, Neopaney A, Fitzsimmons R, Kalb RE, Mease PJ, Craig ET, Koplin J, Takeshita[...]

By sjmartinez • January 8, 2024

Silva BJA, Krogstad PA, Teles RMB, Andrade PR, Rajfer J, Ferrini MG, Yang OO, Bloom BR, Modlin RL. IFN-γ-mediated control of SARS-CoV-2 infection through nitric[...]

By sjmartinez • January 3, 2024

2023 has given us much to celebrate in the department of medicine. I would like to take this opportunity to thank YOU for all that you do[...]

By sjmartinez • December 27, 2023

Yee D, Lee K, Huang MY, Kingston P, Korouri E, Peterson H, Armstrong AW. Assessing the Quality, Comprehensiveness, and Readability of Online Patient Health Resources[...]

By sjmartinez • December 21, 2023